MedPath

Co-Aleva

Brand Name: Co-Aleva

Generic Name: Ebastine + Betamethasone (as Sodium Phosphate)

Active
Registration Number

DRP-12813

Dosage Form

Film-Coated Tablet

Issuance Date

July 1, 2024

Expiry Date

September 19, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength10 mg/500 mcg
PackagingAlu/Alu Blister Pack x 10's B(ox of 50's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antihistamine/Corticosteroid
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

EbastineActive
Monograph: Ebastine
Betamethasone (as Sodium Phosphate)Active
Monograph: betamethasone (as sodium phosphate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform